CHOC is the largest Brineura infusion center in the US to treat Batten disease, a rare neurological condition.
Dr. Raymond Wang
His mother’s keen eye and a pediatrician’s intuition ultimately led to an unexpected diagnosis of MPS Type II.
Isabella is in the early stages of a clinical trial for a drug intended to treat a rare pediatric disease called Mucopolysaccharidosis IIIA.
CHOC is grateful to recently have received three generous gifts that will help care for more than 185,000 babies, kids and teens each year.
CHOC is one of the first hospitals in the United States to offer Brineura, as the first and only treatment for Batten disease.
Thanksgiving at CHOC is a special time. In celebration, members of the CHOC Children’s family express what they’re grateful for this year.